Genital human papillomavirus infections: Knowledge, perception of risk, and actual risk in a nonclinic population of young women

Journal of Women's Health

Volumn 6, Issue 1, 1997, Pages 113-121

  Ramirez, Jacqueline E ^a   Ramos, Debbie M ^a   Clayton, Lisa ^a   Kanowitz, Saul ^a   Moscicki, Anna Barbara ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONDYLOMA; CONTROLLED STUDY; DIAGNOSTIC TEST; EMOTION; FEMALE; HUMAN; NORMAL HUMAN; PERCEPTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SCORING SYSTEM; SELF EVALUATION; SEXUAL BEHAVIOR; WART VIRUS;

EID: 33845426578     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1997.6.113     Document Type: Article

References (32)

1. Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983;80:3812.
2. Yee, C, Krishnan-Hewlett I, Barker C, et al. Presence and expression of human papillomavirus sequence- Human cervical carcinoma cell lines. Am J Pathol 1985;119:361.
3. McCance DJ, Camptom MJ, Clarkson PK, et al. Prevalence of human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and invasive carcinoma of the cervix. Br J Obstet Gynaecol 1985;92:1101.
4. Herrington CS. Control of HPV replication: Implications for squamous neoplasia. J Pathol 1996;178:237.
5. Ullman CG, Emery VC. Transforming proteins of human papillomaviruses. Rev Med Virol 1996;6:39.
6. Kast M, Feltkamp MCW, Ressing ME, Vierboom MPM, Brandt RMP, Melief CJM. Cellular immunity against human papillomavirus-associated cervical cancer. Semin Virol 1996;7:117.
7. Montenarh M. Marker genes for cytotoxic exposure: p53. Stem Cells (Dayt) 1995;13(Suppl 1):136.
8. Biro FM, Rosenthal SL, Wildey LS, Hillard PA. Self-reported health concerns and sexual behaviors in adolescents with cervical dysplasia: A pilot study. J Adolesc Health 1991;12:391.
9. Vail-Smith K, White DM. Risk level, knowledge, and preventive behavior for human papillomaviruses among sexually active college women. J College Health 1992;40:227.
10. Leonardo C, Chrisler JC. Women and sexually transmitted diseases. Women Health 1992;18:1.
11. Moscicki AB. Human papillomavirus infections. Adv Pediatr 1992;39:257.
12. Moscicki AB. Genital HPV infections in children and adolescents. Obstet Gynecol Clin North Am 1996;23:675.
13. von Krogh G. Clinical relevance and evaluation of genitoanal papillomavirus infections in the male. Semin Dermatol 1992;11:229.
14. Moscicki AB. Comparison between methods for human papillomavirus (HPV) DNA testing: A model for self-testing in young women. J Infect Dis 1993;167:723.
15. Moscicki AB, Palefsky J, Smith G, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol 1993;82:78.
16. Taylor GD. Why are there so many myths about AIDS? Can Med Assoc J 1993;148:1675.
17. Golden LL, Anderson WT. AIDS prevention: Myths, misinformation and health policy perceptions. J Health Soc Policy 1992;3:37.
18. Millstein SG, Moscicki AB, Broering JM. Female adolescents at high, moderate, and low risk of exposure to HIV: Differences in knowledge, beliefs, and behavior. J Adolesc Health 1994;15:133.
19. Cates W Jr. The epidemiology and control of sexually transmitted diseases in adolescents. In: Schydlower M, Shafer MA, eds. AIDS and other sexually transmitted diseases. Philadelphia: Hanley & Belfus, 1990:409.
20. Moscicki AB, Millstein SG, Broering J, Irwin CE Jr. Risks of human immunodeficiency virus infection among adolescents attending three diverse clinics. J Pediatr 1993;122:813.
21. Biro FM, Rosenthal SL, Stanberry LR. Knowledge of gonorrhea in adolescent females with a history of STD. Clin Pediatr (Phila) 1994;33:601.
22. DiClemente RJ, Boyer CB, Morales ED. Minorities and AIDS; Knowledge, attitudes and misconceptions among black and Latino adolescents. Am J Public Health 1988;78:55.
23. Moscicki AB, Palefsky J, Gonzales J, Schoolnik G. Human papillomavirus infection in sexually active adolescent females: Prevalence and risk factors. Pediatr Res 1990;28:507.
24. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472.
25. Isacsohn M, Dolberg L, Sabag SG, et al. The inter-relationship of herpes virus, papilloma 16/18 virus infection and Pap smear pathology in Israeli women. Isr J Med Sci 1994;30:383.
26. Kann L, Warren CW, Harris WA, et al. Youth risk behavior surveillance - United States, 1993. MMWR CDC Surveill Summ 1995;44:1.
27. Ericksen KP, Trocki KF. Sex, alcohol and sexually transmitted disease: A national survey. Fam Plann Perspect 1994;26:257.
28. Suligoi B, Giuliani M, Binkin N. The national STD sur- veillance system in Italy: results of the first year of activity. STD Surveillance Working Group. Int J STD AIDS 1994;5:93.
29. Brookes JL, Haywood S, Green J. Adjustment to the psychological and social sequelae of recurrent genital herpes simplex infection. Genitourin Med 1993;69:384.
30. Funke BL, Nicholson ME. Factors affecting patient compliance among women with abnormal Pap smears. Patient Educ Couns 1993;20:5.
31. Filiberti A, Tamburini M, Stefanen B, et al. Psychological aspects of genital human papillomavirus infection: A preliminary report. J Psychosom Obstet Gynaecol 1993;14:145.
32. Jenkins D, Sherlaw-Johnson C, Gallivan S. Can papilloma virus testing be used to improve cervical cancer screening? Int J Cancer 1996;65:768.